Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepithelioma-like cancer of the stomach

International Journal of Cancer

Volumn 84, Issue 4, 1999, Pages 339-343

  Kume, Tohru ^a   Oshima, Koichi ^a   Yamashita, Yuichi ^a   Shirakusa, Takayuki ^a   Kikuchi, Masahiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER IMMUNOLOGY; CANCER STAGING; CARCINOGENESIS; CARCINOMA CELL; CELL FUNCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

AGED; ANTIGENS, CD95; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; FAS LIGAND PROTEIN; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; INTERLEUKIN-10; LYMPHATIC METASTASIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RNA, VIRAL; STOMACH NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032804501     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990820)84:4<339::AID-IJC1>3.0.CO;2-2     Document Type: Article

References (20)

1. BADLEY, A.D., MCELHINNY, J.A., LEIBSON, P.J., LYNCH, D.H., ALDERSON, M.R. and PAYA, C.V., Upregulation of Fas ligand expression by human immunodeficient virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol., 70, 199-206 (1996).
2. BELLGRAU, D., GOLD, D., SELAWRY, H., MOORE, J., FRANZUSOFF, A. and DUKE, R.C., A role for CD95 ligand in preventing graft rejection. Nature (Lond.), 377, 630-632 (1995).
3. BURKE, A.P., YEN, T.S., SHEKITKA, K.M. and SOBIN, L.H., Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod. Pathol., 3, 377-380 (1990).
4. FUKUYAMA, M., HAYASHI, Y., IWASAKI, Y., CHONG, J., OOBA, T., TAKIZAWA, T., KOIKE, M., MIZUTANI, S., MIYAKI, M. and HIRAI, K., Epstein-Barr virus associated gastric adenocarcinoma and Epstein-Barr virus infection of the stomach. Lab. Invest., 71, 73-81 (1994).
5. GRIFFITH, T.S., BRUNNER, T., FLETCHER, S.M., GREEN, D.R. and FERGUSON, T.A., Fas ligand-induced apoptosis as a mechanism of immune privilege. Science, 17, 1189-1192 (1995).
6. HERBST, H., Foss, H.D., SAMOL, J., ARAUJO, I., KLOTZBACH, H., KRAUSE, H., AGATHANGGELOU, A., NIEDOBITEK, G. and STEIN, H., Frequent expression of interleukin-10 by Epstein-Barr-virus-harboring tumor cells of Hodgkin's disease. Blood, 87, 2918-2929 (1996).
7. HIGAKI, K., YANO, H. and KOJIRO, M., Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Amer. J. Pathol., 149, 429-437 (1996).
8. HUS, D.H., DE WAAL MALEFYT, R., FIORENTINO, D.F., DANG, M.N., VIEIRA, P., DE VRIES, J., SPITS, H., MOSMANN, T.R. and MOORE, K.W., Expression of interleukin-10 activity by Epstein-Barr-virus protein BCRF1. Science, 250, 830-832 (1990).
9. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER, The general rules for the gastric cancer study (12th ed.) Kanehara Shuppan, Tokyo (1993).
10. KÄGI, D., LEDERMANN, B., BÜRKI, K. and ZINKERNAGEL, R.M., Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Ann. Rev. Immunol., 14, 207-232 (1996).
11. KOBAYASHI, N., HAMAMOTO, Y., YAMAMOTO, N., ISHII, A., YONEHARA, M. and YONEHARA, S., Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc. nat. Acad. Sci. (Wash.), 87, 9620-9624 (1990).
12. KOJIMA, H., SHINOHARA, N., HANAOKA, S., SOMEYA-SHIROTA, Y., TAKAGAKI, Y., OHNO, H., SAITO, T., KATAYAMA, T., YAGITA, H. and OKUMURA, K., Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity, 1, 357-364 (1994).
13. O'CONNELL, J., O'SULLIVAN, G.C., COLLINS, J.K. and SHANAHAN, F., The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. exp. Med., 184, 1075-1082 (1996).
14. OHFUJI, S., OSAKI, M., TSUJITANI, S., IKEGUCHI, M., SAIRENJI, T. and ITO, H., Low frequency of apoptosis in Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma. Int. J. Cancer, 68, 710-715 (1996).
15. + T lymphocytes. Int. J. Cancer, 62, 5-10 (1995).
16. + T-lymphocytes. Lab. Invest., 75, 67-76 (1996).
17. STRAND, S., HOFMANN, W.J., HUG, H., MÜLLER, M., OTTO, G., STRAND, D., MARIANI, S.M., STREMMEL, W., KRAMMER, P.H. and GALLE, P.R., Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nature (Med.), 12, 1361-1366 (1996).
18. SUDA, T., TAKAHASHI, T., GOLSTEIN, P. and NAGATA, S., Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell, 75, 1169-1178 (1993).
19. WATANABE, H., ENJOJI, M. and IMAI, T., Gastric carcinoma with lymphoid stroma: its morphologic characteristics and prognostic correlation. Cancer, 38, 234-243 (1976).
20. WELLER, M., FREI, K., GROSCURTH, P., KRAMMER, P.H., YONEKAWA, Y. and FONTANA, A., Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells: induction and modulation of sensitivity by cytokines. J. clin. Invest., 94, 954-964 (1994).